The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients

Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?

(2020) Maurizio Guastalegname et al.   CLINICAL INFECTIOUS DISEASES

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

(2020) Maria Garcia‐Cremades et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin

(2020) Ehud Chorin et al.   HEART RHYTHM

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection

(2020) Jacques Fantini et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

(2020) Eli S. Rosenberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19: learning from experience

(2020) The Lancet   LANCET

First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment

(2020) Kathy Leung et al.   LANCET

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

(2020) Joseph T. Wu et al.   NATURE MEDICINE

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

(2020) Joshua Geleris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

(2020) Bo Yu et al.   Science China-Life Sciences

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

(2020) Wei Tang et al.   BMJ-British Medical Journal

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

(2020) Matthieu Mahévas et al.   BMJ-British Medical Journal

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

(2020) Jia Liu et al.   Cell Discovery

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

(2020) Caleb P. Skipper et al.   ANNALS OF INTERNAL MEDICINE

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

(2020) Samia Arshad et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Risk Factors for Mortality in Patients with COVID-19 in New York City

(2020) Takahisa Mikami et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

(2020) Alexandre B. Cavalcanti et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

(2020) David R. Boulware et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study

(2020) Andrew Ip et al.   PLoS One

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

(2020) Jean-Christophe Lagier et al.   Travel Medicine and Infectious Disease

Covid-19: Risk of second wave is very real, say researchers

(2020) Jacqui Wise   BMJ-British Medical Journal